JP2013525493A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525493A5
JP2013525493A5 JP2013509217A JP2013509217A JP2013525493A5 JP 2013525493 A5 JP2013525493 A5 JP 2013525493A5 JP 2013509217 A JP2013509217 A JP 2013509217A JP 2013509217 A JP2013509217 A JP 2013509217A JP 2013525493 A5 JP2013525493 A5 JP 2013525493A5
Authority
JP
Japan
Prior art keywords
formulation
concentration
galactomannan
present
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013509217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525493A (ja
JP5794744B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/035165 external-priority patent/WO2011140203A2/en
Publication of JP2013525493A publication Critical patent/JP2013525493A/ja
Publication of JP2013525493A5 publication Critical patent/JP2013525493A5/ja
Application granted granted Critical
Publication of JP5794744B2 publication Critical patent/JP5794744B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013509217A 2010-05-05 2011-05-04 安定化された眼用ガラクトマンナン処方物 Active JP5794744B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33151110P 2010-05-05 2010-05-05
US61/331,511 2010-05-05
PCT/US2011/035165 WO2011140203A2 (en) 2010-05-05 2011-05-04 Stabilized ophthalmic galactomannan formulations

Publications (3)

Publication Number Publication Date
JP2013525493A JP2013525493A (ja) 2013-06-20
JP2013525493A5 true JP2013525493A5 (enExample) 2014-05-08
JP5794744B2 JP5794744B2 (ja) 2015-10-14

Family

ID=44626461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013509217A Active JP5794744B2 (ja) 2010-05-05 2011-05-04 安定化された眼用ガラクトマンナン処方物

Country Status (16)

Country Link
US (2) US20110275593A1 (enExample)
EP (1) EP2566447B1 (enExample)
JP (1) JP5794744B2 (enExample)
KR (2) KR20130060228A (enExample)
CN (2) CN102939074A (enExample)
AR (1) AR081015A1 (enExample)
AU (1) AU2011248129B2 (enExample)
BR (1) BR112012028308B1 (enExample)
CA (1) CA2798069C (enExample)
ES (1) ES2809304T3 (enExample)
MX (1) MX2012012826A (enExample)
NZ (1) NZ603345A (enExample)
SG (2) SG10201804305SA (enExample)
TW (1) TWI606841B (enExample)
WO (1) WO2011140203A2 (enExample)
ZA (1) ZA201208199B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2009000985A1 (es) * 2008-04-26 2010-01-15 Alcon Res Ltd Composicion oftalmica que comprende entre 0,16 y 0,19% p/v de un galactomanano, alrededor de 0,7% p/v de un borato, cis-diol y menos de 5 ppm de concentracion de cationes divalentes; y su uso para lubricar el ojo.
TWI492769B (zh) * 2009-09-23 2015-07-21 Alcon Res Ltd 可注射的水性眼用組成物及其使用之方法
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
UA113434C2 (uk) * 2012-05-04 2017-01-25 Алкон Рісерч, Лтд. Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
KR20190036520A (ko) 2016-06-27 2019-04-04 아칠리온 파르마세우티칼스 인코포레이티드 의학적 장애를 치료하기 위한 퀴나졸린 및 인돌 화합물
CN115089547A (zh) * 2016-10-12 2022-09-23 Ps治疗有限公司 人工泪液、隐形眼镜和药物载体组合物及其使用方法
US11583496B2 (en) 2016-10-12 2023-02-21 PS Therapy Inc. Drug vehicle compositions and methods of use thereof
US11260035B2 (en) 2016-10-12 2022-03-01 Ps Therapies Ltd Topical compositions and methods of use thereof
AU2018227849B2 (en) 2017-03-01 2022-04-28 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
EP3841086B1 (en) 2018-08-20 2025-04-23 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
JP7443375B2 (ja) 2018-09-06 2024-03-05 アキリオン ファーマシューティカルズ, インコーポレーテッド 医学的障害の治療のための大環状化合物
JP7504088B2 (ja) 2018-10-16 2024-06-21 ジョージア ステイト ユニバーシティー リサーチ ファウンデーション インコーポレイテッド 医学的障害の治療のための一酸化炭素プロドラッグ
TWI757773B (zh) 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
JP2023515073A (ja) 2020-02-20 2023-04-12 アキリオン ファーマシューティカルズ, インコーポレーテッド 補体因子d媒介障害の処置用のヘテロアリール化合物
US20250171423A1 (en) 2020-09-23 2025-05-29 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders
WO2025186703A1 (en) 2024-03-04 2025-09-12 Alcon Inc. Carbamoylphenylboronic acid-containing acrylic monomers and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8028A (en) * 1851-04-08 Hokse-poweb
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
DE3827561C1 (enExample) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
DE69839355T2 (de) * 1997-07-29 2009-06-04 Alcon Laboratories, Inc., Fort Worth Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat
GB9808461D0 (en) * 1998-04-22 1998-06-17 Innovative Tech Ltd Solid borate-diol interaction products
US7084130B2 (en) * 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
TWI434926B (zh) 2006-12-11 2014-04-21 Alcon Res Ltd 眼用組成物中聚氧化乙烯-聚氧化丁烯(peo-pbo)嵌段共聚物之使用
TW200904485A (en) * 2007-05-18 2009-02-01 Alcon Res Ltd Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions
CL2009000985A1 (es) * 2008-04-26 2010-01-15 Alcon Res Ltd Composicion oftalmica que comprende entre 0,16 y 0,19% p/v de un galactomanano, alrededor de 0,7% p/v de un borato, cis-diol y menos de 5 ppm de concentracion de cationes divalentes; y su uso para lubricar el ojo.
WO2010091287A1 (en) 2009-02-05 2010-08-12 Alcon Research, Ltd. Process for purifying guar

Similar Documents

Publication Publication Date Title
JP2013525493A5 (enExample)
CA2798069A1 (en) Stabilized ophthalmic galactomannan formulations
JP6130741B2 (ja) ソフトコンタクトレンズ用眼科組成物
JP7288289B2 (ja) 水性眼科組成物
WO2016042163A3 (en) Ophthalmic drug compositions
JP2018021007A5 (enExample)
JP2015514751A5 (enExample)
AR070824A1 (es) Suspensiones para inyeccion intravitrea de triamcinolona acetonido de baja viscosidad, altamente floculadas
JP2016503058A5 (enExample)
JP5176132B2 (ja) 眼科用剤
JP2019142979A (ja) 水性液剤
JP2021046382A (ja) 制汗剤組成物
JP2016188259A (ja) 水性眼科組成物
JP6177594B2 (ja) 水性眼科組成物
JP2014534215A5 (enExample)
JP5922505B2 (ja) グリチルリチン酸含有水性眼科組成物
KR102288699B1 (ko) 수성 의약 조성물
TW201722437A (zh) 眼科組成物
JP5897075B2 (ja) 粘膜適用組成物
JP2015518873A5 (enExample)
JP5916560B2 (ja) 粘膜適用組成物
WO2013008716A1 (ja) 水性眼科組成物
JP2014015417A (ja) 水性眼科組成物